Winton Matthew
Chief Commercial and Business
Winton Matthew has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2025.
On the most recent filing, Winton Matthew is listed as Chief Commercial and Business at CervoMed Inc. Inside the rolling window, Winton Matthew reported 3 open-market purchases totaling $117K in CRVO and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 CRVO shares on Nov 14, 2025, worth $76K.
Companies traded
Other insiders at CRVO
Insider Buying
$117K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Winton Matthew made?
Winton Matthew has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Winton Matthew trade?
Winton Matthew has filed SEC Form 4 disclosures for 1 company, including CRVO.
When was Winton Matthew's most recent SEC Form 4 filing?
Winton Matthew's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2025.
What is Winton Matthew's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Winton Matthew is listed as Chief Commercial and Business.
What is Winton Matthew's total buy and sell value in the current window?
Inside the rolling retention window, Winton Matthew bought $117K and sold $0 based on SEC Form 4 filings.
What was Winton Matthew's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 CRVO shares on 2025-11-14, worth $76K, per SEC Form 4 filings.